| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |